XIANGCAI CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.63 CNY | -1.49% |
|
-0.60% | -11.72% |
| Apr. 16 | Xiangcai Co.,Ltd announces an Equity Buyback for CNY 80 million worth of its shares. | CI |
| Apr. 15 | Xiangcai Returns to Profit in 2023; Shares Jump 4% | MT |
| Sales 2024 * | 3.56B 491M | Sales 2025 * | 3.64B 502M | Capitalization | 18.96B 2.62B |
|---|---|---|---|---|---|
| Net income 2024 * | 158M 21.82M | Net income 2025 * | 179M 24.72M | EV / Sales 2024 * | 5.33 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.21 x |
| P/E ratio 2024 * |
112
x | P/E ratio 2025 * |
112
x | Employees | 2,146 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 27.27% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.15% | ||
| 1 week | +0.90% | ||
| Current month | -1.61% | ||
| 1 month | -10.03% | ||
| 3 months | -14.59% | ||
| 6 months | -15.24% | ||
| Current year | -10.39% |
1 week
6.38
6.87
1 month
6.387.55
Current year
6.248.25
1 year
6.2410.30
3 years
6.0815.59
5 years
4.4120.13
10 years
3.2220.13
| Managers | Title | Age | Since |
|---|---|---|---|
Shuang Jing
DFI | Director of Finance/CFO | 63 | - |
Jun Jiang
PSD | President | 48 | - |
Jian Ming Shi
CHM | Chairman | 56 | 18-01-14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jin Qi Wang
BRD | Director/Board Member | 59 | - |
Qin Wang
CHM | Chairman | 63 | - |
Jian Ming Shi
CHM | Chairman | 56 | 18-01-14 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 31 M€ | +1.43% | - | |
| 0.00% | 34 M€ | +1.44% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 6.63 | -1.49% | 16 864 550 |
| 24-04-18 | 6.73 | +0.15% | 26,570,770 |
| 24-04-17 | 6.72 | +2.75% | 19,563,630 |
| 24-04-16 | 6.54 | -2.97% | 25,537,340 |
| 24-04-15 | 6.74 | +4.33% | 34,535,790 |
End-of-day quote Shanghai S.E., April 17, 2024
More quotes
XIANGCAI CO., LTD, formerly Harbin High-Tech (Group) Co., Ltd, is a China-based company principally engaged in the real estate business. The Company is also involved in soybean deep processing, pharmaceutical production and waterproofing membrane manufacturing and sales businesses. Its real estate business is engaged in residential and industrial real estates development business, as well as property management business. Its soybean deep processing business provides soybean protein isolate, soybean tissue protein and soybean nutritious food. Its pharmaceutical business is mainly engaged in the production and marketing of thymopeptide enteric-coated tablets and other drugs for the treatment of immune system. Its waterproof coil business is engaged in the manufacture and sales of polyethylene polypropylene fiber coils, load-bearing coil and joint profiles.
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.39% | 2.66B | |
| +53.18% | 91.88B | |
| +34.48% | 69.38B | |
| +12.78% | 61.72B | |
| +6.20% | 41.2B | |
| +20.97% | 29.69B | |
| +16.56% | 28.81B | |
| +12.01% | 21.69B | |
| +8.34% | 16.64B | |
| -6.21% | 12.45B |
- Stock Market
- Equities
- 600095 Stock
